BRIEF-Kempharm Appoints Richard W. Pascoe As CEO

Reuters2023-01-09

Jan 9 (Reuters) - KemPharm Inc :

* KEMPHARM ANNOUNCES BOARD AND LEADERSHIP CHANGES TO SUPPORT ITS TRANSFORMATION INTO A LEADING RARE DISEASE COMPANY

* KEMPHARM INC - MATTHEW R. PLOOSTER NAMED CHAIRMAN OF BOARD OF DIRECTORS

* KEMPHARM INC - RICHARD W. PASCOE APPOINTED CHIEF EXECUTIVE OFFICER

* KEMPHARM INC - TRAVIS C. MICKLE, TRANSITIONS TO PRESIDENT

* KEMPHARM INC - JOSHUA SCHAFER APPOINTED CHIEF COMMERCIAL OFFICER AND EXECUTIVE VICE PRESIDENT OF BUSINESS DEVELOPMENT

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2302752577?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-01-09 20:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2302752577","market":"us","top_or_hot":-1,"title":"BRIEF-Kempharm Appoints Richard W. Pascoe As CEO","media":"Reuters","content":"<html><body><p>Jan 9 (Reuters) - KemPharm Inc   :</p><p>   * KEMPHARM ANNOUNCES BOARD AND LEADERSHIP CHANGES TO SUPPORT ITS TRANSFORMATION INTO A LEADING RARE DISEASE COMPANY</p><p>   * KEMPHARM INC - MATTHEW R. PLOOSTER NAMED CHAIRMAN OF BOARD OF DIRECTORS</p><p>   * KEMPHARM INC - RICHARD W. PASCOE APPOINTED CHIEF EXECUTIVE OFFICER</p><p>   * KEMPHARM INC - TRAVIS C. MICKLE, TRANSITIONS TO PRESIDENT</p><p>   * KEMPHARM INC - JOSHUA SCHAFER APPOINTED CHIEF COMMERCIAL OFFICER AND EXECUTIVE VICE PRESIDENT OF BUSINESS DEVELOPMENT</p><p>Source text for Eikon:    Further company coverage:   </p><p>((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Kempharm Appoints Richard W. Pascoe As CEO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Kempharm Appoints Richard W. Pascoe As CEO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2023-01-09 20:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Jan 9 (Reuters) - KemPharm Inc   :</p><p>   * KEMPHARM ANNOUNCES BOARD AND LEADERSHIP CHANGES TO SUPPORT ITS TRANSFORMATION INTO A LEADING RARE DISEASE COMPANY</p><p>   * KEMPHARM INC - MATTHEW R. PLOOSTER NAMED CHAIRMAN OF BOARD OF DIRECTORS</p><p>   * KEMPHARM INC - RICHARD W. PASCOE APPOINTED CHIEF EXECUTIVE OFFICER</p><p>   * KEMPHARM INC - TRAVIS C. MICKLE, TRANSITIONS TO PRESIDENT</p><p>   * KEMPHARM INC - JOSHUA SCHAFER APPOINTED CHIEF COMMERCIAL OFFICER AND EXECUTIVE VICE PRESIDENT OF BUSINESS DEVELOPMENT</p><p>Source text for Eikon:    Further company coverage:   </p><p>((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2302752577","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2302752577","pubTimestamp":1673266831,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Jan 9 (Reuters) - KemPharm Inc   :   * KEMPHARM ANNOUNCES BOARD AND LEADERSHIP CHANGES TO SUPPORT IT","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","BK4139":"生物科技","LABP":"Landos Biopharma, Inc.","BK4007":"制药","BK4023":"应用软件","CGEM":"Cullinan Therapeutics","LHDX":"Lucira Health, Inc.","BK4196":"保健护理服务","ONTF":"ON24, Inc.","SANA":"Sana Biotechnology, Inc."},"translate_title":"简介-Kempharm任命Richard W.Pascoe为首席执行官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SANA":0.9,"APR":0.9,"KMPH":0.9,"LHDX":0.9,"CGEM":0.9,"ONTF":0.9,"LABP":0.9},"content_text":"Jan 9 (Reuters) - KemPharm Inc   :   * KEMPHARM ANNOUNCES BOARD AND LEADERSHIP CHANGES TO SUPPORT ITS TRANSFORMATION INTO A LEADING RARE DISEASE COMPANY   * KEMPHARM INC - MATTHEW R. PLOOSTER NAMED CHAIRMAN OF BOARD OF DIRECTORS   * KEMPHARM INC - RICHARD W. PASCOE APPOINTED CHIEF EXECUTIVE OFFICER   * KEMPHARM INC - TRAVIS C. MICKLE, TRANSITIONS TO PRESIDENT   * KEMPHARM INC - JOSHUA SCHAFER APPOINTED CHIEF COMMERCIAL OFFICER AND EXECUTIVE VICE PRESIDENT OF BUSINESS DEVELOPMENTSource text for Eikon:    Further company coverage:   ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2302752577","isCrawlerRequest":true}